Publications
349
Citations
27,573
Est. group size
~9
Recurring co-author estimate
Active years
42
Publishing since 1985
Typically publishes in teams of ~12 · 5% small-team papers (≤3 authors) · across 39 venues
- Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trial
BMJ Open Respiratory Research · 2026
- TETON-PPF Clinical Trial of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis: Preliminary Baseline Demographics
American Journal of Respiratory and Critical Care Medicine · 2025
- Teton Phase 3 Clinical Trials of Inhaled Treprostinil in the Treatment of Idiopathic Pulmonary Fibrosis: Annual Update of Preliminary Baseline Data
American Journal of Respiratory and Critical Care Medicine · 2025
- Reply to Borrás-Blasco <i>et al.</i> : How Adherence Shapes Persistence in IPF Treatment: A Call for Real-World Insight
Annals of the American Thoracic Society · 2025
- Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency
American Journal of Respiratory and Critical Care Medicine · 2024
- Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial
American Journal of Respiratory and Critical Care Medicine · 2024
- Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes
American Journal of Respiratory and Critical Care Medicine · 2024
- Use of Race-Specific Equations in Pulmonary Function Tests Impedes Potential Eligibility for Care and Treatment of Pulmonary Fibrosis
Annals of the American Thoracic Society · 2024
- Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study
Respiratory Research · 2024
- Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry
American Journal of Respiratory and Critical Care Medicine · 2024
- Acute exacerbations in patients with progressive pulmonary fibrosis
ERJ Open Research · 2024
- Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial
Annals of the American Thoracic Society · 2024
- Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary Fibrosis
CHEST Pulmonary · 2024
- The interstitial lung disease patient pathway: from referral to diagnosis
ERJ Open Research · 2024
- Computational deconvolution of cell type-specific gene expression in COPD and IPF lungs reveals disease severity associations
BMC Genomics · 2024
- American Journal of Respiratory and Critical Care Medicine×30
- CHEST Journal×20
- European Respiratory Journal×14
- Annals of the American Thoracic Society×11
- Respiratory Research×8
- Jamie Sheth
Medicine · University of Michigan
- Justin M. Oldham
Medicine · University of Michigan
- KR Flaherty
Medicine · University of Michigan
- Adam Martin‐Schwarze
Medicine · University of Michigan
- J. Oldham
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile